Anne-Marie N Fortier

6PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersCancer cell biologyProteomics and intermolecular interactions (excl. medical proteomics)Cancer diagnosisMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 25, 2024
Osteopontin is a therapeutic target that drives breast cancer recurrence.

Yu Gu, Tarek Taifour, Tung Bui

|Jun 07, 2024
A YAP-centered mechanotransduction loop drives collective breast cancer cell invasion.

Antoine A Khalil, Daan Smits, Peter D Haughton

|Jul 02, 2022
Endosomal LC3C-pathway selectively targets plasma membrane cargo for autophagic degradation.

Paula P Coelho, Geoffrey G Hesketh, Annika Pedersen

|May 23, 2022
The case for cancer-associated fibroblasts: essential elements in cancer drug discovery?

Gabrielle Brewer, Anne-Marie Fortier, Morag Park

|Jun 02, 2021
Cholesterol-Induced Metabolic Reprogramming in Breast Cancer Cells Is Mediated via the ERRα Pathway.

Faegheh Ghanbari, Anne-Marie Fortier, Morag Park

|Aug 23, 2020
GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer.

Qin Wu, Wail Ba-Alawi, Genevieve Deblois

Pageof 1